ABBLO PHARMA ApS: Financial statements 2023
CVR: 34080534
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
ABBLO PHARMA ApS (CVR 34080534) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 806,142 and a net result of DKK 107,380 compared with DKK 300,769 the year before. That is a decrease of 23.7% compared with the year before. Equity in the 2023 report amounted to DKK -221,042. The company had 1 employee in the financial year.
- Gross Profit
- DKK 806,142
- Profit/Loss
- DKK 107,380
- Equity
- DKK -221,042
- Total Assets
- DKK 1,498,675
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 806 t. | 107 t. | -221 t. | 1 |
| 2022 | - | 1.1 mio. | 301 t. | -328 t. | 1 |
| 2021 | - | 740 t. | 285 t. | -629 t. | 1 |
| 2020 | - | 376 t. | 214 t. | -914 t. | 1 |
| 2019 | - | 306 t. | 100 t. | -1.1 mio. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
ABBLO PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 1,056,147, and the net result was DKK 300,769.
About ABBLO PHARMA ApS
ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The board consists of Mie Hjerrild Petersen (chair) and Nic Borch-Christensen. The company is owned by ABBLO S.à.r.l. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity in the 2025 report amounted to DKK -238,088.